High antiviral activity of snake phospholipases A2 against HIV-1 and SARS-CoV-2 : inactivation of viruses and blocking the cell-cell fusionE-posterBasic science
Engineering CR3022 with improved SARS-CoV-2 binding affinity to investigate the relationship between antigen binding and neutralization activityOral abstract session with live Q&ABasic science
Interpreting COVID-19 serological (antibody) test results when the pre-test probability (prevalence) needs to be estimated by the serological test itselfE-posterBasic science
SARS-CoV-2 infection and vaccination induces human coronaviruses cross-reactive antibodiesOral abstract session with live Q&ABasic science
CRISPR-Cas13b can potently suppress replication of SARS-CoV-2 and mutant strainsOral abstract session with live Q&ABasic science
Evolution of SARS-CoV-2 envelope, membrane, nucleocapsid and spike structural proteins from the beginning of the pandemic to September 2020: a global and regional approach by epidemiological weekOral abstract session with live Q&ABasic science
SARS CoV-2 RNA wastewater surveillance in South AfricaOral abstract session with live Q&ABasic science
High resolution profiling of pathways of escape for SARS-CoV-2 Spike-binding antibodiesOral abstract session with live Q&ABasic science
Two-month follow-up of persons with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, Zambia, September 2020E-posterBasic science
Seroprevalence of SARS-CoV-2 in Nasarawa State, North Central Nigeria: population-based sero-epidemiological surveysE-posterBasic science
seek-warrow-warrow-eseek-e1 - 10 of 88 items